ALK gene mutations are significant drivers in the development of NSCLC, though they occur in only about 2%–7% of cases, often as echinoderm microtubule-associated protein-like 4 (EML4)-ALK fusions [1, 2]. This evidence concerns the gene ALK and non-small cell lung carcinoma.